EUVIMEDAtrasti EUVIMED
Open access · CC BY 4.0

Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell

Nikolaos Stefanakis iD, Jasmine Xi, Jessica Jiang, Shai Shaham iD

Development · 2025

DOI: 10.1242/dev.204622 ↗

At a glance

Journal article in Development, 2025. Written by Nikolaos Stefanakis and 3 co-authors. Institution: Laboratory of Developmental Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA. Major MEDLINE topics: Caenorhabditis elegans, Mesoderm, Forkhead Transcription Factors, Endothelial Cells. Cited 1 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: Rockefeller University, NIH HHS, Leon Levy Foundation.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Endothelial cells form the inner layer of blood vessels and play key roles in circulatory system development and function. A variety of endothelial cell types have been described through gene expression and transcriptome studies; nonetheless, the transcriptional programs that specify endothelial cell fate and maintenance are not well understood. To uncover such regulatory programs, we studied the C. elegans head mesodermal cell (HMC), a non-contractile mesodermal cell bearing molecular and functional similarities to vertebrate endothelial cells. Here, we demonstrate that a Forkhead transcription factor, LET-381, is required for HMC fate specification and maintenance of HMC gene expression. DMD-4, a DMRT transcription factor, acts downstream of and in conjunction with LET-381 to mediate these functions. Independently of LET-381, DMD-4 also represses the expression of genes associated with a different, non-HMC, mesodermal fate. Our studies uncover essential roles for FoxF transcriptional regulators in endothelial cell development and suggest that FoxF co-functioning target transcription factors promote specific non-contractile mesodermal fates.

Subjects

MeSH terms (MEDLINE)

Caenorhabditis elegansMesodermForkhead Transcription FactorsEndothelial CellsCaenorhabditis elegans ProteinsTranscription FactorsAnimalsGene Expression Regulation, DevelopmentalCell Differentiation

Author keywords

Caenorhabditis elegansdmd-4let-381DMRTEndothelial cell developmentFoxF

Substances

Forkhead Transcription FactorsCaenorhabditis elegans ProteinsTranscription Factors

Authors and institutions

  • Laboratory of Developmental Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.

ORCID profiles: Nikolaos Stefanakis, Shai Shaham

Funding

  • Rockefeller University
  • NIH HHS
  • Leon Levy Foundation
  • NINDS NIH HHS
  • National Institutes of Health

Cite

APA

Stefanakis, N., Xi, J., Jiang, J., & Shaham, S. (2025). Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell. Development. https://doi.org/10.1242/dev.204622

Vancouver

Stefanakis N, Xi J, Jiang J, Shaham S. Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell. Development. 2025. doi:10.1242/dev.204622

BibTeX
@article{Stefanakis2025,
  author = {Stefanakis, Nikolaos and Xi, Jasmine and Jiang, Jessica and Shaham, Shai},
  title = {Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell},
  journal = {Development},
  year = {2025},
  doi = {10.1242/dev.204622}
}
Start for free →